Pharmaceutical compound to prevent and treat focal tissular lesions and infections, method and applicators
OwnerRicardo Levismaninventor
Life of this patent
Estimating the term…
Abstract
A therapeutic compound, methods and applicators to prevent and treat focal tissular lesions and infections in mammals is made by the mixture of an antiseptic powder and an antiseptic liquid, wherein the compound may be employed for an “assisted integration” through the “bone socket arrangement” pre or post-implantation by medication in a patient, for preventing or curing by direct contact diseases within the mouth and also to treat skin inflammations, infections, aphthas, herpes simplex infections, ulcers, burns, and other externally illness, to promote healing and bone growth and to chemical debridement.
Claims40
A compound exhibiting a broad cicatrizing action, ample antibacterial, antifungus and antiviral spectrum to prevent and treat focal tissue lesions and infections in mammals, the compound also providing the ability to fast chemical debridement of necrotic tissues and dead bacteria residues, properties for an “assisted integration” through the bone “socket arrangement pre or post implantation” of an implant, and means to promote tissue healing, wherein the compound comprises:
- a) an antiseptic liquid comprising, per each 100 millilitres thereof:
- acetic acid, aqueous solution 6% v/v, in a range between 1.7 and 1.9 millilitres;
- derivative of sulphonic acid, 100% v/v, in a range between 1.1 and 1.3 millilitres;
- citric acid, 100% v/v, in a range between 0.15 and 0.35 grams;
- phosphoric acid, 85% p/p, in a range between 1.7 and 1.9 millilitres;
- tri-sodium citrate, 100% p/p, in a range between 0.8 and 1.2 grams;
- sodium acetate, 100% p/p, in a range between 0.4 and 0.6 grams;
- and
- distilled water, s.q. 100 millilitres;
- and
- b) an antiseptic powder comprising, per each 110 grams thereof:
- zinc oxide, 100% p/p, in a range between 35 and 45 grams;
- carboximethyl-cellulose, 100% p/p, in a range between 12 and 18 grams;
- methyl-cellulose, 100% p/p, in a range between 12 and 18 grams;
- gum Arabic, 100% p/p, in a range between 12 and 18 grams;
- zinc peroxide, 100% p/p, in a range between 3 and 7 grams;
- boric acid, 100% p/p, in a range between 8 and 12 grams;
- and
- barium sulphate, 100% p/p, in a range between 8 and 12 grams.
A method for obtaining a compound exhibiting a broad cicatrizing, ample antibacterial, antifungus and antiviral spectrum to prevent and treat focal tissue lesions and infections in mammals, also capable of fast chemical debridement of necrotic tissues and dead bacteria residues, properties for an “assisted integration” through the “bone socket arrangement”, pre or post-implantation, and means to promote tissue healing, wherein the compound comprises:
- a) an antiseptic liquid comprising, per each 100 millilitres thereof:
- acetic acid, aqueous solution 6% v/v, in a range between 1.7 and 1.9 millilitres;
- derivative of sulphonic acid, 100% v/v, in a range between 1.1 and 1.3 millilitres;
- citric acid, 100% p/p, in a range between 0.15 and 0.35 grams;
- phosphoric acid, 85% v/v, in a range between 1.7 and 1.9 millilitres;
- tri-sodium citrate, 100% p/p, in a range between 0.8 and 1.2 grams;
- sodium acetate, 100% p/p, in a range between 0.4 and 0.6 grams, and
- sterile distilled water, s.q. 100 millilitres, and
- b) an antiseptic powder comprising, per each 110 grams thereof:
- zinc oxide, 100% p/p, in a range between 35 and 45 grams;
- carboximethyl-cellulose, 100% p/p, in a range between 12 and 18 grams;
- methyl-cellulose, 100% p/p, in a range between 12 and 18 grams;
- gum Arabic, 100% p/p, in a range between 12 and 18 grams;
- zinc peroxide, 100% p/p, in a range between 3 and 7 grams;
- boric acid, 100% p/p, in a range between 8 and 12 grams;
- and
- barium sulphate, 100% p/p, in a range between 8 and 12 grams;
- and wherein the method comprises the step of:
- mixing the antiseptic liquid with the antiseptic powder with a sterile spatula over a sterile glass slab to obtain a paste.
Dependencies are inferred from the claim text.